Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Polymer Group (CPG) is a specialized contract research organization and consultancy focused on materials science and polymer chemistry within the medical device and pharmaceutical sectors. Founded by scientists from MIT and Massachusetts General Hospital, the company provides expert services in material characterization, product development, and regulatory consulting. CPG is globally recognized for its contributions to orthopedic biomaterials, particularly in the advancement of ultra-high molecular weight polyethylene (UHMWPE) and hydrogel-based delivery systems. Their multidisciplinary team assists clients from the initial proof-of-concept stage through to failure analysis and litigation support. The firm operates ISO-accredited laboratories to ensure high-quality analytical testing for complex biomedical applications. Their services are essential for companies navigating the intersection of material science and clinical performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Polymer Group.